Sunday, Nov 29, 2020 | Last Update : 09:27 AM IST

zydus cadila

India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial

The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients

13 Aug 2020 11:01 AM

Seven Indian pharma players race to develop vaccine for deadly coronavirus

Leading vaccine major Serum Institute of India has said that it is hoping to develop a COVID-19 vaccine by the year-end

19 Jul 2020 4:08 PM

Zydus Cadila to end COVID-19 vaccine trial in 2021

Cadila’s vaccine candidate, known as ZyCov-D, is one of dozens being developed around the world to fight the coronavirus pandemic

17 Jul 2020 3:24 PM

Zydus receives tentative approval from USFDA for Tofacitinib tablets

Tofacitinib is used to treat moderate to severe forms of rheumatoid arthritis, company said in a BSE filing.

06 Apr 2019 5:04 PM

Zydus Cadila to launch seasonal flu vaccine

Company said vaccine provides protection from four influenza viruses — H1N1, H3N2, Type B or Brisbane and Type B.

24 Feb 2017 2:42 PM

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT